GlassScriptPhysician profile
Martin Rutkowski
NPI 1780950923
$62,095.49
in general payments reported to CMS, 2019-2025
20 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,302 · 2020: $405 · 2021: $797 · 2022: $19K · 2023: $39K · 2024: $21.95 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,500.00 |
| Food and Beverage | $203.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collagen Matrix, INC | $59,250.00 | 2022-2025 | |
| Stryker Corporation | $1,120.41 | 2019-2022 | |
| Novocure INC. | $455.77 | 2019-2021 | |
| Nuvasive, INC. | $241.83 | 2021 | |
| 4web, INC. | $144.09 | 2020 | |
| Ucb, INC. | $126.28 | 2019 | |
| Abbvie INC. | $111.36 | 2022-2024 | Botox |
| Integra Lifesciences Corporation | $109.14 | 2020-2021 | |
| Aesculap, INC. | $108.18 | 2020-2021 | |
| Gt Medical Technologies, INC | $91.71 | 2021 | |
| Medtronic, INC. | $58.31 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $58.04 | 2022-2023 | Ultomiris |
| Omniscient Neurotechnology America LTD | $52.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $35.52 | 2022 | |
| Brainlab, INC. | $25.33 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.50 | 2023 | |
| Kuros Biosciences USA, INC | $21.89 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.66 | 2023 | |
| Eisai INC. | $21.41 | 2021 | |
| Tanabe Pharma America, INC. | $19.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Rutkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.